Medtronic plc says it has received approval from the U.S. FDA for expanded MRI labeling of its InterStim™ II and InterStim™ … continue reading “FDA Approves Expanded Labeling of Medtronic MRI Leads”
Urology
U.S. Launch for Boston Scientific SpaceOAR Vue™ Hydrogel
Next-generation Hydrogel spacer offers enhanced visibility via CT Scan to optimize treatment planning for patients undergoing radiation for prostate cancer. … continue reading “U.S. Launch for Boston Scientific SpaceOAR Vue™ Hydrogel”
Two New FDA-Approved Bladder and Bowel Control Therapies
Medtronic plc, has received approval from the US FDA for its InterStim™ Micro neurostimulator and InterStim™ SureScan™ MRI leads. Background … continue reading “Two New FDA-Approved Bladder and Bowel Control Therapies”
Rezūm™ Water Vapor BPH Therapy Effective After Five Years
New clinical study results say the Rezūm System provided significant, sustained improvement of lower urinary tract symptoms (LUTS) and quality of … continue reading “Rezūm™ Water Vapor BPH Therapy Effective After Five Years”
Urology Robot Tech First for Harley Street
King Edward VII’s Hospital has become the first in the Harley Street Medical Area to introduce the latest da Vinci surgical … continue reading “Urology Robot Tech First for Harley Street”
Medtronic Submits InterStim™ Micro Neurostimulator and SureScan™ MRI Leads to FDA
Medtronic plc tells us it has filed a pre-market approval (PMA) supplement with the U.S. FDA for approval of its … continue reading “Medtronic Submits InterStim™ Micro Neurostimulator and SureScan™ MRI Leads to FDA”
Boston Scientific’s New TACTRA™ Penile Prosthesis
This new implant provides patients with a durable, natural-feeling implant for the treatment of erectile dysfunction. Background Erectile dysfunction (ED) … continue reading “Boston Scientific’s New TACTRA™ Penile Prosthesis”
Study Supports Interstim™ Therapy for Overactive Bladder
InterStim Sacral Neuromodulation offers sustained 5 year efficacy and quality of life
New “Blue Light” System Targets Detection of Bladder Cancer
Blue Light Cystoscopy showcased at U.S. Annual Breakthroughs Conference
Could Water Jet Ablation Replace TURPS?
Aquablation demonstrates TURP-like efficacy with reduced rate of sexual side effects
Pioneering ‘Bladder GPS’ Wins Queen’s Award for Enterprise
Mediplus is delighted that its S-Cath™ system has picked up the Queen’s Award for Enterprise: Innovation
U.S. Commercial Launch of Signostics Uscan™ Ultrasound Bladder Scanner
New system promises industry-leading scan accuracy and volume measurement
Series A Financing Will See ConvertX™ Nephroureteral Stent System Progress Towards Commercialization
BrightWater Medical Closes $5.2 Million funding round led by OSF Ventures, the corporate investment arm of regional health system OSF HealthCare
Pre-Clinical Studies of ConvertX Ureteral Stent at Society of Interventional Radiology
Device designed to eliminate invasive procedure in treatment of ureteral obstructions
Medtronic Launches Percutaneous Tibial Neuromodulation System for Treatment of Overactive Bladder (OAB)
NURO™ is a minimally invasive nerve stimulation system delivering therapy over 12 weeks and offering long term relief
Medtronic Reinforces End Stage Renal Disease Portfolio with Bellco Acquisition
Aiming, as it does, at delivering comprehensive care solutions, Medtronic sets sights on ESRD market dominance